After the Roll-over
Back to: Humira’s Rich Media Banner (Moderate to Severe RA Indication)
Brand: Humira (adalimumab), Injection
Parent Company: Abbvie
Drug Type: Boxed Warning
Drug Category: Multiple Indications/Therapeutic Areas
Campaign: Post-Launch
Targeting: Patients
Patient Website: https://www.humira.com/
HCP Website: https://www.humirapro.com/
Parent Company: Abbvie
Drug Type: Boxed Warning
Drug Category: Multiple Indications/Therapeutic Areas
Campaign: Post-Launch
Targeting: Patients
Patient Website: https://www.humira.com/
HCP Website: https://www.humirapro.com/